Simulations Plus, Inc. (NASDAQ:SLP), a leader in AI-driven drug development, has announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its acquisition by Altaris, LLC.
This development marks the fulfillment of a key regulatory condition required to finalize the acquisition.
The transaction is anticipated to be completed in the latter half of 2026.